RECHLOR
Live / Registered — Registered (as of 07 Jul 2026)
What this means for you
Registered since 07 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Jul 2032: the §8 declaration of use).
Record
- Serial number
- 97565652
- Registration number
- 8330402
- Mark type
- Word mark
- Filed
- 25 Aug 2022
- Published for opposition
- 19 May 2026
- Registered
- 07 Jul 2026
- Next maintenance filing
- §8 declaration of use, due by 07 Jul 2032 (grace period to 07 Jan 2033)
- Attorney of record
- L. S. VanLandingham III
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical and nutraceutical preparations in the form of syrups, tablets and ointments for the treatment of kidney dysfunction, kidney disease, and the prevention and treatment of chronic kidney disease (CKD) and chronic renal failure (CRF)
Owner
- Genix Pharmaceuticals Corporation, Vancouver, BC, CA
- Genix Pharmaceuticals Corporation, Vancouver, BC, CA
- Genix Pharmaceuticals Corporation, Vancouver, BC, CA
Prosecution history
- 07 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
- 19 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 May 2026 — PUBLISHED FOR OPPOSITION
- 13 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 Apr 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 21 Apr 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 21 Apr 2026 — LETTER OF SUSPENSION E-MAILED
- 21 Apr 2026 — SUSPENSION LETTER WRITTEN
- 21 Feb 2025 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 19 Feb 2025 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 19 Feb 2025 — INQUIRY TO SUSPENSION E-MAILED